Lymphocytopenia causes: Difference between revisions
Jump to navigation
Jump to search
| Line 8: | Line 8: | ||
==Causes== | ==Causes== | ||
===Life Threatening Causes=== | ===Life Threatening Causes=== | ||
| Line 15: | Line 14: | ||
===Causes by Organ System=== | ===Causes by Organ System=== | ||
{|style="width:80%; height:100px" border="1" | {|style="width:80%; height:100px" border="1" | ||
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular''' | |style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular''' | ||
| Line 35: | Line 31: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"|[[Blinatumomab]], [[Cabozantinib]], [[Eribulin]], [[Lorcaserin]], [[Saxagliptin]], [[Sorafenib]], [[Thrombin human]] | |bgcolor="Beige"|[[Blinatumomab]], [[Cabozantinib]], [[Eribulin]], [[Ixabepilone]], [[Lorcaserin]], [[Saxagliptin]], [[Sorafenib]], [[Thrombin human]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 136: | Line 132: | ||
{{col-break|width=33%}} | {{col-break|width=33%}} | ||
*[[Eribulin]] | *[[Eribulin]] | ||
*[[Ixabepilone]] | |||
* [[Saxagliptin]] | * [[Saxagliptin]] | ||
* [[Sorafenib]] | * [[Sorafenib]] | ||
Revision as of 19:17, 13 February 2015
|
Lymphocytopenia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphocytopenia causes On the Web |
|
American Roentgen Ray Society Images of Lymphocytopenia causes |
|
Risk calculators and risk factors for Lymphocytopenia causes |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Causes
Life Threatening Causes
Common Causes
Causes by Organ System
| Cardiovascular | No underlying causes |
| Chemical/Poisoning | No underlying causes |
| Dental | No underlying causes |
| Dermatologic | No underlying causes |
| Drug Side Effect | Blinatumomab, Cabozantinib, Eribulin, Ixabepilone, Lorcaserin, Saxagliptin, Sorafenib, Thrombin human |
| Ear Nose Throat | No underlying causes |
| Endocrine | No underlying causes |
| Environmental | No underlying causes |
| Gastroenterologic | No underlying causes |
| Genetic | No underlying causes |
| Hematologic | No underlying causes |
| Iatrogenic | No underlying causes |
| Infectious Disease | No underlying causes |
| Musculoskeletal/Orthopedic | No underlying causes |
| Neurologic | No underlying causes |
| Nutritional/Metabolic | No underlying causes |
| Obstetric/Gynecologic | No underlying causes |
| Oncologic | No underlying causes |
| Ophthalmologic | No underlying causes |
| Overdose/Toxicity | No underlying causes |
| Psychiatric | No underlying causes |
| Pulmonary | No underlying causes |
| Renal/Electrolyte | No underlying causes |
| Rheumatology/Immunology/Allergy | No underlying causes |
| Sexual | No underlying causes |
| Trauma | No underlying causes |
| Urologic | No underlying causes |
| Miscellaneous | No underlying causes |